92 related articles for article (PubMed ID: 2931479)
1. Murine leukemic cells inhibit IL 2 production by susceptible syngeneic splenocytes.
Jenski LJ; Ledford T
J Immunol; 1985 Nov; 135(5):3178-83. PubMed ID: 2931479
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts.
LeFor AT; Eisenthal A; Rosenberg SA
J Immunol; 1988 Jun; 140(11):4062-9. PubMed ID: 3259603
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 and interleukin-2 production in resistant and susceptible inbred mice infected with Trypanosoma congolense.
Mitchell LA; Pearson TW; Gauldie J
Immunology; 1986 Feb; 57(2):291-6. PubMed ID: 3485076
[TBL] [Abstract][Full Text] [Related]
4. Cytokine production and utilization by the motheaten mouse.
Stanton TH; Tubbs C; Clagett J
J Immunol; 1985 Dec; 135(6):4021-6. PubMed ID: 2933456
[TBL] [Abstract][Full Text] [Related]
5. Experimental murine Trypanosoma congolense infections. I. Administration of anti-IFN-gamma antibodies alters trypanosome-susceptible mice to a resistant-like phenotype.
Uzonna JE; Kaushik RS; Gordon JR; Tabel H
J Immunol; 1998 Nov; 161(10):5507-15. PubMed ID: 9820527
[TBL] [Abstract][Full Text] [Related]
6. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 2 deficiency in murine Leishmaniasis donovani and its relationship to depressed spleen cell responses to phytohemagglutinin.
Reiner NE; Finke JH
J Immunol; 1983 Sep; 131(3):1487-91. PubMed ID: 6224858
[TBL] [Abstract][Full Text] [Related]
8. In vitro splenic T cell responses of diverse mouse genotypes after oronasal exposure to mouse hepatitis virus, strain JHM.
Smith AL; Winograd DF; de Souza MS
Lab Anim Sci; 1991 Apr; 41(2):106-11. PubMed ID: 1658436
[TBL] [Abstract][Full Text] [Related]
9. Immunoregulation in disseminated murine histoplasmosis: disturbances in the production of interleukins 1 and 2.
Watson SR; Schmitt SK; Hendricks DE; Bullock WE
J Immunol; 1985 Nov; 135(5):3487-93. PubMed ID: 3900209
[TBL] [Abstract][Full Text] [Related]
10. [Immunobiological characterization of murine LB leukemia and the LBC cell line].
Hajos SE; Mongini C; Waldner C; Sánchez Lockhart M; Gravisaco MJ; Roig I; Fernańdez T; Alvarez E
Medicina (B Aires); 1996; 56 Suppl 1():45-56. PubMed ID: 9224974
[TBL] [Abstract][Full Text] [Related]
11. Early T cell unresponsiveness in mice with candidiasis and reversal by IL-2: effect on T helper cell development.
Spaccapelo R; Del Sero G; Mosci P; Bistoni F; Romani L
J Immunol; 1997 Mar; 158(5):2294-302. PubMed ID: 9036977
[TBL] [Abstract][Full Text] [Related]
12. Regional oral tolerance in transgenic 2C mice.
Margenthaler JA; Flye MW
Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
[TBL] [Abstract][Full Text] [Related]
13. Early loss of precursors of CTL and IL 2-producing cells in the development of neonatal tolerance to alloantigens.
Carnaud C; Ishizaka ST; Stutman O
J Immunol; 1984 Jul; 133(1):45-51. PubMed ID: 6233373
[TBL] [Abstract][Full Text] [Related]
14. Suppression of cell-mediated immune responses after total lymphoid irradiation (TLI). I. Characterization of suppressor cells of the mixed lymphocyte reaction.
Weigensberg M; Morecki S; Weiss L; Fuks Z; Slavin S
J Immunol; 1984 Feb; 132(2):971-8. PubMed ID: 6140288
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of tolerance induction: splenocytes from total lymphoid irradiated mice inhibit the IL-2 pathway in TCR-activated CD4 cells.
Field EH; Ye ZX; Rouse TM
J Immunol; 1996 Nov; 157(9):3796-803. PubMed ID: 8892608
[TBL] [Abstract][Full Text] [Related]
16. Immune response to murine neuroblastoma: effects of in vitro culture of the tumor. Mitogen and mixed lymphocyte culture responses, interleukin-2 production, suppression and natural killer activity.
Leclercq G; Willems J; Joniau M
J Clin Lab Immunol; 1986 Nov; 21(3):117-23. PubMed ID: 2951523
[TBL] [Abstract][Full Text] [Related]
17. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with IL-2-secreting tumor cells stimulates the generation of IL-2-responsive T cells and prevents the development of unresponsiveness.
Zier KS; Salvadori S; Cronin KC; Gansbacher B
Cancer Gene Ther; 1994 Mar; 1(1):43-50. PubMed ID: 7621237
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of lymphocyte transformation by disrupted murine oncornavirus.
Fowler AK; Twardzik DR; Reed CD; Weislow OS; Hellman A
Cancer Res; 1977 Dec; 37(12):4529-31. PubMed ID: 144563
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
Cohen P; Vourka-Karussis U; Weiss L; Slavin S
J Immunol; 1993 Nov; 151(9):4803-10. PubMed ID: 8409438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
